#South Korea #Seoul #AI Health Tech #NAVER D2SF #Soundable Health

NAVER D2SF Strengthens Commitment to Health Tech with New Investment

Introduction
NAVER D2SF, the corporate venture capital branch of South Korea's NAVER Corporation, has reaffirmed its commitment to the healthcare technology sector through a recent follow-on investment in Soundable Health, a burgeoning startup that utilizes AI-driven acoustic analysis for clinical diagnostics. This investment follows NAVER D2SF's initial participation in Soundable Health's seed funding round back in 2019, highlighting the startup's impressive growth and product-market fit within the U.S. healthcare market.

A Closer Look at Soundable Health's Innovations

Founded with the ambition to revolutionize health monitoring, Soundable Health has crafted proprietary AI models capable of analyzing acoustic signals produced by the human body. Their flagship offering, named proudP, serves as a clinical-grade solution that assesses urinary symptoms by analyzing urine flow sounds. This innovation addresses critical conditions, including benign prostatic hyperplasia (BPH) and overactive bladder (OAB). The application draws from a substantial dataset, derived from more than 500,000 real-world home tests, ensuring it achieves 97% accuracy without the need for specialized hardware.

In a notable achievement, proudP has already garnered adoption in over 130 urology clinics and has been used by approximately 50,000 patients nationwide. As it stands, this technology allows individuals to conduct uroflowmetry tests from the comfort of their homes, significantly enhancing accessibility while maintaining high standards of quality and data privacy that comply with FDA Class II medical device regulations.

An Expanding Market Opportunity

As the digital health landscape evolves, Soundable Health anticipates further growth in 2026, especially with an expected expansion in insurance reimbursement eligibility, including Medicare. Furthermore, the company is enhancing its business-to-business partnerships with pharmaceutical, medical device, and consumer electronics firms, while also exploring applications for respiratory health through cough analysis.

CEO Catherine Song, Ph.D., emphasized the vital role of continuous and accessible health monitoring as global populations age. She believes that acoustic AI technology can play a transformative role in facilitating early disease detection and improving chronic care management, thereby supporting independent living for older adults. Song's vision positions the company favorably for scaling its offerings in urology, respiratory health, and potentially beyond.

Comments from NAVER D2SF

Sanghwan Yang, head of NAVER D2SF, commented on the company's commitment to supporting startups that meet real market needs. He expressed confidence in Soundable Health’s ability to maintain momentum in the U.S. healthcare sector due to its innovative technology and clear execution strategy. NAVER D2SF’s investment signifies recognition of the increasing demand for user-friendly health monitoring solutions.

Conclusion

Soundable Health is positioned at the forefront of healthcare innovation. Its developments not only highlight the integration of technology and healthcare but also illustrate how startup companies can significantly impact patient access to diagnostics and care. With NAVER D2SF's continued investment and support, Soundable Health is set to advance its mission, potentially transforming the approach to health monitoring, diagnostics, and patient engagement.

For more information, please visit Soundable Health's website. Together, with NAVER D2SF’s backing, Soundable Health is poised to make waves within the healthcare industry and enhance patient care globally.